Jean-Paul Clozel

Jean-Paul Clozel is the current CEO of Idorsia. Prior to this, they worked for Actelion Pharmaceuticals Ltd from January 2010 to June 2017 as a Senior Scientific Associate in CV pharmacology. Jean-Paul's responsibilities included drug testing on hypertensive rat models, establishing surgically-induced endometriosis-like lesions rat models, and catheterization of vessels for blood pressure measurements in rats & mice. Jean-Paul also conducted vascular reactivity studies of macro and micro-vessels (arteries & veins) of rats and mice.

Jean-Paul Clozel has a University certificate of Animal Experimentation Level 1 from the Faculty of Pharmacy in Nancy France. Jean-Paul also has a Master's degree in Safety Pharmacology-Pre Clinical Drug Expertise from the same school. Lastly, they have a Science degree in Cell Biology and Physiology from the Faculty of Sciences in Reims France.

Olivier Lambert - SVP, Head of Global Pharmaceutical Development & Quality Assurance, Oliver Peinelt - SVP, Group General Counsel, and Simon Jose - EVP, Chief Commercial Officer report to Jean-Paul Clozel.